Twist Bioscience to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results on Friday, November 18, 2022

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2022 fourth quarter and full year ended September 30, 2022, before the opening of the market on … [Read more…]

Saudi Arabia Diagnostic Imaging (X-Ray Imaging Solutions, Ultrasound, MRI, CT, Nuclear Imaging Solutions, Mammography) Markets, Analysis, Competition, Forecast & Opportunities, 2017-2022 & 2023-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia Diagnostic Imaging Market, By Type (X-Ray Imaging Solutions, Ultrasound Systems, MRI Systems, CT Scanners, Nuclear Imaging Solutions, Mammography, Others), By Mobility, By Source, By Application, By End User, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. Saudi Arabia diagnostic imaging market is projected to grow … [Read more…]

Novadip Biosciences Raises Additional EUR 40 Million Bringing Total Company Funding to EUR 88 Million

Funding will support development of next generation orthopedic products that provide accelerated healing through single treatment cures Equity Funding led by CR-CP Life Science Fund, New Science Ventures, Fund+ and SRIW MONT SAINT-GUIBERT, Belgium–(BUSINESS WIRE)–#Belgium–Novadip Biosciences (“Novadip” or “the Company”), a clinical-stage biopharmaceutical company developing a new class of regenerative tissue products to accelerate healing … [Read more…]

AvenCell to Present New Data from Lead Universal CAR T Cell Therapy Program at 64th American Society of Hematology Annual Meeting and Exposition

Oral presentation of updated safety and efficacy data for AVC-101 in relapsed/refractory acute myeloid leukemia Achieves clinical proof of concept with efficacy signal in late-line r/r AML patients and demonstrates rapid CAR T Cell on-off control mechanism of Universal Targeting platform CAMBRIDGE, Mass.–(BUSINESS WIRE)–AvenCell Therapeutics, Inc. announced today that expanded data from its leading Universal … [Read more…]

Presentations on Ropeginterferon Alfa-2b During ASH Annual Meeting Highlight Momentum in the Care of Polycythemia Vera

New presentations to inform applications for ropeginterferon alfa-2b in the treatment of PV BURLINGTON, Mass.–(BUSINESS WIRE)–PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, today announced that new data on ropeginterferon-alfa-2b will be … [Read more…]

Global Digital Diabetes Management Market Report to 2027: Increasing Diabetes-Related Health Expenditure Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Patch Pump), Diabetes Apps, Service, Data Management Software), Device Type (Handheld & Wearables), End User (Hospitals & Self/home healthcare) – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The global digital diabetes management market is projected to reach USD … [Read more…]

Front Porch Expands Memory Care Programs to Meet Increasing Demand for Those with Alzheimer’s and Related Dementias

LOS ANGELES–(BUSINESS WIRE)–An estimated 6.5 million Americans aged 65 and older are living with Alzheimer’s dementia. To help meet the growing need for those requiring memory care, Front Porch Communities and Services continues to expand its resources through innovative services and expanded capacity in multiple locations across California. With 19 senior living and 32 affordable … [Read more…]

Endologix Reports Five-Year Data of the LEOPARD Trial at 2022 Vascular InterVentional Advances (VIVA) Conference

The LEOPARD (Looking at EVAR Outcomes by Primary Analysis of Randomized Data) trial is the first randomized controlled trial (RCT) comparing the outcomes of endovascular aneurysm repair (EVAR) using commercially available devices in a real-world population. IRVINE, Calif.–(BUSINESS WIRE)–#alto—Endologix LLC, a privately held global medical device company dedicated to improving patients’ lives by providing disruptive … [Read more…]

MaaT Pharma Announces Oral and Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting

Oral presentation will detail consolidated results from 81 patients with steroid-resistant, gastrointestinal, acute Graft-versus-Host-Disease (GI-aGvHD) treated with MaaT013 as salvage therapy, as part of an ongoing Early Access Program (EAP). Poster will present detailed results from the Phase 1b clinical trial of MaaT033 in patients with acute myeloid leukemia. MaaT033, the Company’s first Microbiome Ecosystem … [Read more…]

Guaranteed Raises $6.5M Seed Round to Modernize End-of-Life Care

Raising $9.25M to date, Guaranteed’s latest capital raise marks one of the largest pre-Series A rounds for a Black female solo founder. NEW YORK–(BUSINESS WIRE)–Guaranteed, a company providing modern, end-of-life care designed with the patient and caregiver in mind, is pleased to announce it has closed a $6.5M seed round led by BrandProject, with participation … [Read more…]